Sort   by:  
 Page size 
This experiment is designed to evaluate gene expression alterations following treatment with gambogic acid and bortezomib in human HepG2 cells. We find gambogic acid yielded a similar gene expression profile as did bortezomib. Total RNA were extracted from human HepG2 cancer cells treated with gambo...
ORGANISM(S): Homo sapiens 
This experiment is designed to evaluate gene expression alterations following treatment with gambogic acid and bortezomib in human HepG2 cells. We find gambogic acid yielded a similar gene expression profile as did bortezomib.
ORGANISM(S): Homo sapiens 
2012-06-15 | GSE38730 | GEO
Gambogic acid (GA) is an anti-cancer agent in phase Ⅱb clinical trial in China. In HeLa cells, GA inhibited cell proliferation, induced cell cycle arrest at G2/M phase and apoptosis, as showed by results of MTT assay and flow cytometric analysis. Possible target-related proteins of GA were searched ...
ORGANISM(S): Homo sapiens (Human) 
2018-10-24 | PXD002985 | Pride
Gambogic acid (GA) is an anti-cancer agent in phase Ⅱb clinical trial in China. In HeLa cells, GA inhibited cell proliferation, induced cell cycle arrest at G2/M phase and apoptosis, as showed by results of MTT assay and flow cytometric analysis. Possible target-related proteins of GA were searched ...
ORGANISM(S): Homo sapiens (Human) 
2018-10-24 | PXD002975 | Pride
Gene expression profile in human hepatoma HepG2 cells induced by gambogic acid and bortezomib
Sort   by:  
 Page size